{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:44:31Z","timestamp":1794037471086,"version":"4.8.0"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca Corrente"],"award-info":[{"award-number":["Ricerca Corrente"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0222969","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T14:02:38Z","timestamp":1588255358000},"page":"e0222969","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":72,"title":["Interleukin (IL)-17\/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses"],"prefix":"10.1371","volume":"15","author":[{"given":"Laura","family":"Mercurio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5991-8914","authenticated-orcid":true,"given":"Cristina M.","family":"Failla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Capriotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Scarponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Facchiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Pagnanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7537-6833","authenticated-orcid":true,"given":"Cristina","family":"Albanesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cavani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Madonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,4,30]]},"reference":[{"key":"pone.0222969.ref001","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jaad.2015.03.041","article-title":"Angiogenesis and lymphangiogenesis in inflammatory skin disorders","volume":"73","author":"G Varricchi","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"pone.0222969.ref002","first-page":"162","article-title":"Angiogenic properties of normal and psoriatic skin associate with epidermis, not dermis","volume":"61","author":"R Malhotra","year":"1989","journal-title":"Lab Invest"},{"key":"pone.0222969.ref003","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/jidsymp.2011.5","article-title":"The cutaneous vascular system in chronic skin inflammation","volume":"15","author":"R Huggenberger","year":"2011","journal-title":"J Invest Dermatol Symp Proceed"},{"key":"pone.0222969.ref004","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/ajt.13644","article-title":"HLA Class II Antibody Activation of Endothelial Cells Promotes Th17 and Disrupts Regulatory T Lymphocyte Expansion","volume":"16","author":"J Lion","year":"2016","journal-title":"Am J Transplant"},{"key":"pone.0222969.ref005","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1073\/pnas.1011811108","article-title":"Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions","volume":"108","author":"C Taflin","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"pone.0222969.ref006","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/eji.201646723","article-title":"IL-17 and IL-22 in immunity: driving protection and pathology","volume":"47","author":"K Eyerich","year":"2017","journal-title":"Eur J Immunol"},{"key":"pone.0222969.ref007","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.joca.2005.10.004","article-title":"Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts","volume":"14","author":"MC Honorati","year":"2006","journal-title":"OsteoArthritis and Cartilage"},{"key":"pone.0222969.ref008","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1182\/blood-2002-05-1461","article-title":"Interleukin-17 promotes angiogenesis and tumor growth","volume":"101","author":"M Numasaki","year":"2003","journal-title":"Blood"},{"key":"pone.0222969.ref009","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.imlet.2004.11.012","article-title":"Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells","volume":"98","author":"H Takahashi","year":"2005","journal-title":"Immunol Lett"},{"key":"pone.0222969.ref010","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.4049\/jimmunol.0903271","article-title":"IL-17 contributes to angiogenesis in rheumatoid arthritis","volume":"184","author":"SR Pickens","year":"2010","journal-title":"J Immunol"},{"key":"pone.0222969.ref011","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.4049\/jimmunol.1600138","article-title":"IL-17 promotes neutrophil-mediated immunity by activating microvascular pericytes and not endothelium","volume":"197","author":"R Liu","year":"2016","journal-title":"J Immunol"},{"key":"pone.0222969.ref012","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1074\/jbc.M115.690081","article-title":"Interleukin-17A promotes aortic endothelial cell activation via transcriptionally and post-translationally activating p38 mitogen-activated protein kinase (MAPK) pathway","volume":"291","author":"J Mai","year":"2016","journal-title":"J Biol Chem"},{"key":"pone.0222969.ref013","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.4049\/jimmunol.179.6.4135","article-title":"IL-17 enhances chemokine gene expression through mRNA stabilization","volume":"179","author":"J Hartupee","year":"2007","journal-title":"J Immunol"},{"key":"pone.0222969.ref014","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00424-013-1354-5","article-title":"IL-17A potentiates TNFa-induced secretion from human endothelial cells and alters barrier functions controlling neutrophils rights of passage","volume":"466","author":"MH Bosteen","year":"2014","journal-title":"Pflugers Arch\u2014Eur J Physiol"},{"key":"pone.0222969.ref015","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1038\/jid.2013.237","article-title":"IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis","volume":"133","author":"CQF Wang","year":"2013","journal-title":"J Invest Dermatol"},{"key":"pone.0222969.ref016","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3390\/ijms18051000","article-title":"Interleukin 17A promotes lymphocytes adhesion and induces CCL2 and CXCL1 release from brain endothelial cells","volume":"18","author":"DW Wojkowska","year":"2017","journal-title":"Int J Mol Sci"},{"key":"pone.0222969.ref017","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1159\/000430197","article-title":"Interleukin-17 stimulates STAT3-mediated endothelial cell activation for neutrophil recruitment","volume":"36","author":"S Yuan","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"pone.0222969.ref018","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3389\/fimmu.2018.01682","article-title":"The IL-17 family of cytokines in psoriasis: IL-17A and beyond","volume":"9","author":"NC Brembilla","year":"2018","journal-title":"Front Immunol"},{"key":"pone.0222969.ref019","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1038\/jid.2011.234","article-title":"Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis","volume":"131","author":"Y Carrier","year":"2011","journal-title":"J Invest Dermatol"},{"key":"pone.0222969.ref020","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3390\/ijms20061257","article-title":"IL-36, IL-37, and IL-38 cytokines in skin and joint inflammation: a comprehensive review of their therapeutic potential","volume":"20","author":"M-A Boutet","year":"2019","journal-title":"Int J Mol Sci"},{"key":"pone.0222969.ref021","doi-asserted-by":"crossref","first-page":"e123390","DOI":"10.1172\/jci.insight.123390","article-title":"Disrupting the IL-36 and IL-23\/IL-17 loop underlies the efficacy of calcipotriol and corticosteroid therapy for psoriasis","volume":"4","author":"B Germ\u00e0n","year":"2019","journal-title":"JCI Insight"},{"key":"pone.0222969.ref022","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cyto.2016.05.012","article-title":"Interleukin-36 potently stimulates human M2 macrophages, Langerhans cells and keratinocytes to produce pro-inflammatory cytokines","volume":"84","author":"D Dietrich","year":"2016","journal-title":"Cytokine"},{"key":"pone.0222969.ref023","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3389\/fimmu.2019.01162","article-title":"Interleukin-36 in Infectious and Inflammatory Skin Diseases","volume":"10","author":"AL Buhl","year":"2019","journal-title":"Front Immunol"},{"key":"pone.0222969.ref024","doi-asserted-by":"crossref","first-page":"e3318","DOI":"10.3390\/ijms20133318","article-title":"The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis","volume":"20","author":"S Madonna","year":"2019","journal-title":"Int J Mol Sci"},{"key":"pone.0222969.ref025","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1182\/blood-2012-06-439026","article-title":"IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells","volume":"120","author":"S Vigne","year":"2012","journal-title":"Blood"},{"key":"pone.0222969.ref026","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/exd.13228","article-title":"IL-36\u03b3 has proinflammatory effects on human endothelial cells","volume":"26","author":"C Bridgewood","year":"2017","journal-title":"Exp Dermatol"},{"key":"pone.0222969.ref027","doi-asserted-by":"crossref","first-page":"e2344","DOI":"10.1038\/cddis.2016.201","article-title":"Luteolin-7-glucoside inhibits IL-22\/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model","volume":"7","author":"R Palombo","year":"2016","journal-title":"Cell Death Dis"},{"key":"pone.0222969.ref028","doi-asserted-by":"crossref","first-page":"e24307","DOI":"10.1371\/journal.pone.0024307","article-title":"Sirtinol treatment reduces inflammation in human dermal microvascular endothelial cells","volume":"6","author":"A Orecchia","year":"2011","journal-title":"PLoS One"},{"key":"pone.0222969.ref029","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/s41419-018-1143-3","article-title":"IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment","volume":"9","author":"L Mercurio","year":"2018","journal-title":"Cell Death Dis"},{"key":"pone.0222969.ref030","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.it.2017.01.006","article-title":"IL-17 signaling: the yin and the yang","volume":"38","author":"N Amatya","year":"2017","journal-title":"TRENDS Immunol"},{"key":"pone.0222969.ref031","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.4049\/jimmunol.178.10.6017","article-title":"Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation","volume":"178","author":"S Danese","year":"2007","journal-title":"J Immunol"},{"key":"pone.0222969.ref032","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3892\/mmr.2017.6623","article-title":"Effects of interleukin-17 on human retinal vascular endothelial cell capillary tube formation in vitro","volume":"16","author":"G Liu","year":"2017","journal-title":"Mol Med Rep"},{"key":"pone.0222969.ref033","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/exd.13461","article-title":"TNF stimulates IL-6, CXCL8 and VEGF secretion from human keratinocytes via activation of mTOR, inhibited by tetramethoxyluteolin","volume":"27","author":"AB Patel","year":"2017","journal-title":"Exp Dermatol"},{"key":"pone.0222969.ref034","doi-asserted-by":"crossref","first-page":"21264","DOI":"10.1073\/pnas.0907550106","article-title":"Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis","volume":"106","author":"HB Schonthaler","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"pone.0222969.ref035","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1468-3083.2009.03181.x","article-title":"Vascular endothelial growth factor in psoriasis: an indicator of disease severity and control","volume":"23","author":"A Nofal","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"pone.0222969.ref036","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbrc.2007.02.156","article-title":"Sunitinib:a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor","volume":"356","author":"RJ Roskoski","year":"2007","journal-title":"Biochem Biophys Res Comm"},{"key":"pone.0222969.ref037","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1167\/iovs.06-0570","article-title":"Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis","volume":"48","author":"F Bock","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"pone.0222969.ref038","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/cei.12761","article-title":"Distinct expression of interleukin (IL)-36\u03b1, b and g, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease","volume":"184","author":"MA Boutet","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"pone.0222969.ref039","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"L van der Fits","year":"2009","journal-title":"J Immunol"},{"key":"pone.0222969.ref040","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.bbamcr.2006.11.010","article-title":"ERK implication in cell cycle regulation","volume":"1773","author":"JC Chambard","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"pone.0222969.ref041","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1084\/jem.20090207","article-title":"IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway","volume":"206","author":"L Wang","year":"2009","journal-title":"J Exp Med"},{"key":"pone.0222969.ref042","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1096\/fj.08-106831","article-title":"Suppressor of cytokine signaling 1 inhibits IFN-gamma inflammatory signaling in human keratinocytes by sustaining ERK1\/2 activation","volume":"22","author":"S Madonna","year":"2008","journal-title":"FASEB J"},{"key":"pone.0222969.ref043","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1096\/fj.10-172288","article-title":"STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation","volume":"25","author":"R Sestito","year":"2011","journal-title":"FASEB J"},{"key":"pone.0222969.ref044","doi-asserted-by":"crossref","first-page":"e0194667","DOI":"10.1371\/journal.pone.0194667","article-title":"The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression","volume":"13","author":"J Palomo","year":"2018","journal-title":"PLoS One"},{"key":"pone.0222969.ref045","doi-asserted-by":"crossref","first-page":"e0150688","DOI":"10.1371\/journal.pone.0150688","article-title":"The vascular endothelial growth factor inhibitors Ranibizumab and Aflibercept markedly increase expression of atherosclerosis-associated inflammatory mediators on vascular endothelial cells","volume":"11","author":"C Arnott","year":"2016","journal-title":"PLoS One"},{"key":"pone.0222969.ref046","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00262-008-0524-3","article-title":"Anti-angiogenesis: making the tumor vulnerable to the immune system","volume":"57","author":"AW Griffioen","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"pone.0222969.ref047","doi-asserted-by":"crossref","first-page":"50277","DOI":"10.18632\/oncotarget.10364","article-title":"Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment","volume":"7","author":"L van Hooren","year":"2016","journal-title":"Oncotarget"},{"key":"pone.0222969.ref048","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jdermsci.2010.03.023","article-title":"Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis\u2014a possible target for novel therapies?","volume":"58","author":"M Canavese","year":"2010","journal-title":"J Dermatol Sci"},{"key":"pone.0222969.ref049","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jaad.2006.01.038","article-title":"Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy","volume":"54","author":"T Markham","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"pone.0222969.ref050","article-title":"Impact of secukinumab on endothelial dysfunction and other cardiovascular disease parameters in psoriasis patients over 52 weeks","author":"E von Stebut","year":"2019","journal-title":"J Invest Dermatol"},{"key":"pone.0222969.ref051","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jid.2018.09.021","article-title":"Antagonization of IL-17A attenuates skin inflammation and vascular dysfunction in mouse models of psoriasis","volume":"139","author":"R Schuler","year":"2019","journal-title":"J Invest Dermatol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0222969","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T14:02:51Z","timestamp":1588255371000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0222969"}},"subtitle":[],"editor":[{"given":"Michel","family":"Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":51,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0222969","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/767400","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,30]]}}}